Showing 1 - 20 results of 412 Refine Results
  1. 1
    Conference

    Source: 2024 IEEE International Symposium on Biomedical Imaging (ISBI) Biomedical Imaging (ISBI), 2024 IEEE International Symposium on. :1-5 May, 2024

    Relation: 2024 IEEE International Symposium on Biomedical Imaging (ISBI)

  2. 2
    Conference

    Source: 2023 5th International Conference on Geoscience and Remote Sensing Mapping (GRSM) Geoscience and Remote Sensing Mapping (GRSM), 2023 5th International Conference on. :111-115 Oct, 2023

    Relation: 2023 5th International Conference on Geoscience and Remote Sensing Mapping (GRSM)

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
    eBook

    Contributors: Cassano, Enrico, Pesapane, Filippo

    Subject Terms: ductal carcinoma in situ (DCIS), invasive breast carcinoma, breast, biopsy, overtreatment, active surveillance, Contrast-Enhanced Mammography (CEM), Dynamic Contrast Magnetic Resonance Imaging (DCE-MRI), radiomics, artificial intelligence, breast tumor segmentation, convolutional neural network, deep learning, X-ray images, breast cancer, brain metastasis, tissue-specific metastasis, organotropism, cancer metabolism, oxidative phosphorylation (OXPHOS), mitochondria, cyclooxygenase 7b (Cox7b), hereditary breast cancer, cancer susceptibility genes, PALB2, aberrant splicing, functional assay, minigenes, clinical interpretation, cyclin-dependent kinase inhibitor 4 and 6, HER2-low, palbociclib, circulating tumor cells, neoplastic cells, circulating, neoplasms/diagnosis, circulating/pathology, breast neoplasms/pathology, biomarkers, tumor, blood, liquid biopsy, AhR, agonist, ligand, TCDD, triple-negative breast cancer, exploratory subgroup discovery, chemoimmunotherapy, bone metastases, bone scan, follow-up, prognosis, survival, SETD7, molecular subtypes, gene expression, biological processes, HER2, antibody-drug conjugate, trastuzumab-deruxtecan, T-Dxd, communication, decision-making, patient empowerment, ONEST, observers needed to evaluate subjective tests, TILs, sTILs, tumour-infiltrating lymphocytes, triple-negative, reproducibility, international immuno-oncology biomarker working group, European Working Group for Breast Screening Pathology, breast-conserving surgery, radiation, de-escalation, early breast cancer, metastatic breast cancer, BRCA, NGS, HRD score, homologous recombination deficiency, mutational signature, PARPi, platinum salts, metastasis, secretome, immune modulation, tumor microenvironment, drug resistance, therapeutic targets, precision oncology, Medicine and Nursing, Diseases and disorders, Oncology

    File Description: application/octet-stream

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20